 Arrowhead provided a bullish update for its midstage liver disease treatment on Monday, pushing ARWR stock to rocket Tuesday. The post Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease appeared first on Investors Business Daily. 